259.96USD+0.01%Mkt Cap: 21.28B USDP/E: 23.01Last update: 2026-05-26
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinal…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap21.28B USD
Enterprise Value27.30B USD
Revenue (TTM)14.14B USD
Gross Profit4.01B USD
Net Income (TTM)876.50M USD
Revenue/Share170.67 USD
Last Price259.96 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees71.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)23.01
P/E (Forward)13.15
PEG1.09
EV/EBITDA12.12
EV/Revenue1.93
P/S1.48
P/B2.44
EPS (TTM)11.28
EPS (Forward)19.44
52W Range
239.7537% of range293.72
52W High293.72 USD
52W Low239.75 USD
Profitability
Gross Margin28.76%
Oper. Margin10.95%
EBITDA Margin15.93%
Profit Margin6.28%
ROE10.17%
ROA4.77%
Growth
Revenue Growth5.80%
Earnings Growth32.90%
Cash Flow & Leverage
Operating CF1.64B USD
CapEx (TTM)434.50M USD
FCF Margin8.08%
FCF Yield5.37%
Net Debt6.31B USD
Net Debt/EBITDA2.80
Balance Sheet
Debt/Equity0.76
Current Ratio1.73
Quick Ratio1.30
Book Value/Sh104.86 USD
Cash/Share11.96 USD
Dividends
Fwd Div Rate2.880 USD
Trail. Div Rate2.880 USD
Div. Yield1.13%
5Y Avg Yield—
Payout Ratio25.51%
Ex-Div DateMay 29, 2026
Pay DateJun 11, 2026
Splits
Last Split1164:1000
Split DateJul 3, 2023
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)310.12 USD
Target Range270.00 USD – 340.00 USD
# Analysts17
Ownership
Shares Out.82.00M
Float81.60M
Insiders0.35%
Institutions100.56%
Short Interest
Short Ratio4.7d
Short % Float3.85%
Short % Out.3.84%
Shares Short3.16M
Short (prev mo.)3.19M
Technical
SMA 50263.24 (-1.2%)
SMA 200268.48 (-3.2%)
Beta0.88
S&P 52W Chg28.31%
Avg Vol (30d)672.45K
Avg Vol (10d)550.92K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—